KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Ionis Pharmaceuticals (IONS) over the last 13 years, with Q3 2025 value amounting to $37.2 million.

  • Ionis Pharmaceuticals' Non-cash Items fell 3123.84% to $37.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year decrease of 3123.84%. This contributed to the annual value of $43.7 million for FY2024, which is 4436.1% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Non-cash Items of $37.2 million as of Q3 2025, which was down 3123.84% from $42.3 million recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Non-cash Items peaked at $101.8 million during Q1 2021, and registered a low of $9.2 million during Q4 2021.
  • In the last 5 years, Ionis Pharmaceuticals' Non-cash Items had a median value of $54.1 million in 2024 and averaged $54.4 million.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Non-cash Items crashed by 4475.47% in 2021, and later surged by 66365.58% in 2023.
  • Ionis Pharmaceuticals' Non-cash Items (Quarter) stood at $9.2 million in 2021, then rose by 12.1% to $10.3 million in 2022, then skyrocketed by 663.66% to $78.5 million in 2023, then crashed by 44.36% to $43.7 million in 2024, then dropped by 14.87% to $37.2 million in 2025.
  • Its Non-cash Items stands at $37.2 million for Q3 2025, versus $42.3 million for Q2 2025 and $51.9 million for Q1 2025.